Human GABA receptor proteins and polynucleotides encoding...

Details Human GABA receptor proteins and polynucleotides encoding... Human GABA receptor proteins and polynucleotides encoding...

2001-01-18

2003-07-01

Eyler, Yvonne (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S006120, C435S007100, C435S007210, C435S069500, C435S252300, C435S320100, C530S350000, C436S501000, C514S002600

Reexamination Certificate

active

06586582

ABSTRACT:

1. INTRODUCTION
The present invention relates to the discovery, identification, and characterization of novel human polynucleotides encoding proteins that share sequence similarity with animal gamma-amino butyric acid (GABA) receptor subunits. The invention encompasses the described polynucleotides, host cell expression systems, the encoded proteins, fusion proteins, polypeptides and peptides, antibodies to the encoded proteins and peptides, and genetically engineered animals that either lack or over express the disclosed sequences, antagonists and agonists of the proteins, and other compounds that modulate the expression or activity of the proteins encoded by the disclosed sequences that can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of diseases and disorders.
2. BACKGROUND OF THE INVENTION
Membrane proteins play important roles as, inter alia, cell surface markers, receptors, and mediators of signal transduction. GABA receptors bind a potent inhibitory neurotransmitter and this interaction serves as a target for a variety of pharmaceutical agents such as benzodiazepines, barbiturates and alcohol.
3. SUMMARY OF THE INVENTION
The present invention relates to the discovery, identification, and characterization of nucleotides that encode novel human proteins, and the corresponding amino acid sequences of these proteins. The novel human proteins (NHPs) described for the first time herein share structural similarity with membrane receptors such as, but not limited to human and other mammalian GABA receptors.
The novel human nucleic acid sequences described herein, encode alternative proteins/open reading frames (ORFs) of 467, 392, 180, 420, 345, and 133 amino acids in length (see SEQ ID NOS: 2, 4, 6, 8, 10, and 12 respectively).
The invention also encompasses agonists and antagonists of the described NHPs, including small molecules, large molecules, mutant NHPs, or portions thereof that compete with native NHP, peptides, and antibodies, as well as nucleotide sequences that can be used to inhibit the expression of the described NHPs (e.g., antisense and ribozyme molecules, and gene or regulatory sequence replacement constructs) or to enhance the expression of the described NHP sequences (e.g., expression constructs that place the described sequence under the control of a strong promoter system), and transgenic animals that express a NHP transgene, or “knock-outs” (which can be conditional) that do not express a functional NHP. A gene trapped murine ES cell line has been produced that knocks-out a murine ortholog of the described NHPs.
Further, the present invention also relates to processes for identifying compounds that modulate, i.e., act as agonists or antagonists, of NHP expression and/or NHP activity that utilize purified preparations of the described NHPs and/or NHP product, or cells expressing the same. Such compounds can be used as therapeutic agents for the treatment of any of a wide variety of symptoms associated with biological disorders or imbalances.


REFERENCES:
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4631211 (1986-12-01), Houghten
patent: 4689405 (1987-08-01), Frank et al.
patent: 4713326 (1987-12-01), Dattagupta et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5252743 (1993-10-01), Barrett et al.
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5556752 (1996-09-01), Lockhart et al.
patent: 5700637 (1997-12-01), Southern
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5869336 (1999-02-01), Meyer et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
Bailey et al., Bioch. Biophys. Acta 1447(307-312)1999.*
Ogurusu et al., Bioch. Biophys. Acta 1305(15-18)1996.*
Berger and Kimmel, Eds., Methods in Enzymology, 152(432-442)1987.*
Sambrook et al., Molecular Cloning, p. 11.47, 1989.*
Bowie et al., 1990, Science 247:1306-1310, especially p.1306.*
Alexander et al., Proc. Natl. Acad. Sci. 89(3352-3356)1992.*
Bailey, Mark E.S., et al., “Genetic linkage and radiation hybrid mapping of the three human GABAcreceptor &rgr; subunit genes:GABRR1, GABRR2 and GABRR3,” Biochimica et Biophysica Acta, vol. 1447, No. 2-3, Oct. 28, 1999, pp. 307-312, XP000999020.
Ogurusu, Tarou, et al., “Cloning of a putative &Ugr;-aminobutyric acid (GABA) receptor subunit &rgr;3 cDNA,”Biochimica et Biophysica Acta, vol. 1305, No. 1-2, Feb. 7, 1996, pp. 15-18, XP000999706.
Qian, Haohua, et al. “Molecular and Pharmacological Properties of GABA-&rgr; subunits from White Perch Retina,”J. Neurobiol., vol. 37, No. 2, 1998, pp. 305-320, XP000996647.
Cutting, Garry R., et al., “Cloning of the &Ugr;-aminobutyric acid (GABA) &rgr;1 cDNA: A GABA receptor subunit highly expressed in the retina,”Proc. Natl. Acad. Sci. USA.vol. 88, Apr. 1991, pp. 2673-2677, XP002167521.
Cutting, Garry R. et al., “Identification of a Punative &Ugr;-aminobutyric acid (GABA) receptor rho2cDNA and colocalization of the genes encoding rho2(GABRR2) and rho1(GABRR1) to human chromosome 6q14-q21 and mouse chromosome 4,”Genomics, vol. 12, No. 4, Apr. 1992, pp. 801-806, XP00099703.
Wegelius, Katri, et al., “Distribution of GABA receptor &rgr;subunit Transcripts in the rat brain,”European Journal of Neuroscience, vol. 10, Jan. 1998, pp. 350-357, XP000996648.
Bird et al, 1988, “Single-Chain Antigen-Binding Proteins”, Science 242:423-426.
Bitter et al, 1987, “Expression and Secretion Vectors for Yeast”, Methods in Enzymology 153:516-544.
Colbere-Garapin et al, 1981, “A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells”, J. Mol. Biol. 150:1-14.
Gautier et al, 1987, “&agr;-DNA IV:&agr;anomeric and &bgr;-anomeric tetrahymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physiochemical properties and poly (rA) binding”, Nucleic Acids Research 15(16):6625-6641.
Greenspan et al, 1993, “Idiotypes: structure and immunogenicity”, FASEB Journal 7:437-444.
Huse et al, 1989, “Generation of a Large Combinatorial Library of the immunoglobulin Repertoire in Phage Lambda”, Science 246:1275-1281.
Huston et al, 1988, “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli”, Proc. Natl. Acad. Sci. USA 85:5879-5883.
Inoue et al, 1987, “Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and R Nase H”, FEBS Letters 215(2):327-330.
Inoue et al, 1987, “Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides”, Nucleic Acids Research 15(15):6131-6149.
Inouye & Inouye, 1985, “Up-promoter mutations in the lpp gene ofEscherichia coli”, Nucleic Acids Research 13(9):3101-3110.
Janknecht et al, 1991, “Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus”, PNAS 88:8972-8976.
Kohler & Milstein, 1975, “Continuous cultures of fused cells secreting antibody of predefined specificity”, Nature 256:495-497.
Logan et al, 1984, “Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection”, Proc. Natl. Acad. Sci. USA 81:3655-3659.
Lowy et al, 1980, “Isolation of Transforming DNA: Cloning the Hamster aprt Gene”, Cell 22:817-823.
Morrison et al, 1984, “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains”, Proc. Natl. Acad. Sci. USA 81:6851-6855.
Mulligan & Berg, 1981, “Selection for animal cells that express theEscherichia coligene coding for xanthine-guanine phosphoribosyltransferase”, Proc. Natl. Acad. Sci. USA 78(4):2072-2076.
Neuberger et al, 1984, “Recombinant antibodies possessing novel effector functions”, Nature 312:604-608.
Nisonoff, 1991, “Idiotypes: Concepts and Applications”, J. of Immunology 147:2429-2438.
Ruther et al, 1983, “Easy identification of cDNA clones”, EMBO Journal 2(10):1791-1794.
Santerre et al, 1984, “Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells”, Gene 30:147-156.
Sarin et al, 1988, “Inhibition of acquired

Affiliated with

Also associated with

Rating

Human GABA receptor proteins and polynucleotides encoding... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human GABA receptor proteins and polynucleotides encoding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human GABA receptor proteins and polynucleotides encoding... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3009323